Another Study Suggests Planned Parenthood at Fault in Abortion Drug Deaths

National   |   Steven Ertelt   |   Jun 17, 2008   |   9:00AM   |   WASHINGTON, DC

Another Study Suggests Planned Parenthood at Fault in Abortion Drug Deaths

RSS Newsfeed Email article
Add to My Yahoo! Printer friendly

by Steven Ertelt Editor
June 17
, 2008

Washington, DC ( — Another study suggests Planned Parenthood is at fault in the deaths of women in the United States from the abortion drug RU 486. The abortion business had been telling women to use the drug in a different way than the FDA guidelines suggested and the study shows it contributed to the deaths.

So far, eight women have died from the use of the abortion drug, including women going to Planned Parenthood abortion centers in California.

Planned Parenthood had been telling women to use the abortion drug vaginally, even though the FDA indicated oral use is safer for women.

It wasn’t until four California women all died within a week of using the abortion drug they received from Planned Parenthood abortion businesses that it changed its policy to conform to the FDA protocol.

A new study from University of Michigan scientists suggests the off-label use of a drug given in association with the abortion pill may be responsible for the women’s deaths.

When women get the abortion drug RU 486, they take two pills.

One, mifepristone, essentially deprives the growing unborn child of food and water and the second, misoprostol, causes contractions allowing women to give birth to the dead baby.

In animal and cell culture studies, the University of Michigan researchers found that misoprostol, when given directly in the reproductive tract, suppresses key immune responses and can allow a normally non-threatening bacterium, Clostridium sordellii, to cause deadly infection.

According to post-mortem reports on the women who died from the abortion drug, this vaginal use allowed the bacteria to cause the fatal infections.

When absorbed through the stomach, however, the drug did not compromise immune defenses or cause illness, the researchers found.

The results provide evidence why doctors should avoid giving misoprostol vaginally and underscore the wisdom of giving it by mouth instead, says David Aronoff, M.D., an infectious disease specialist who led the study.

Dr. Randy O’Bannon, the director of research for National Right to Life, tells that earlier studies showed the mifepristone drug also caused problems.

"Authors of this study claim that vaginally administered misoprostol may suppress the body’s immune response, making infection more likely. Earlier studies have suggested that RU 486, or mifepristone, the first drug used in the chemical abortion process, may itself have immunosuppressive qualities," he explained.

O’Bannon said he’s not convinced the University of Michigan study is the final chapter in the story of the women’s abortion drug deaths.

"As long as both of these drugs are being used as abortifacients, it will be important to try and nail down how one or both of these drugs contributed to eight known infection deaths among women to took the two drug regimen," he said.

Regardless of the study’s findings, Dr. O’Bannon told that abortion facilities that violated the FDA abortion drug protocols put women at risk.

"Though the FDA specifically cautioned that the safety of at home vaginal self administration of misoprostol had not been established, many clinics had their patients follow this course anyway," he said.

"That much of the abortion industry disregarded the FDA protocol for so long displays either a disregard for the safety of women or a sense that they somehow knew better than the government’s top scientists," O’Bannon concluded. "In either case, these are hardly the sort of people women should be trusting with their lives."

Despite the eventual change in the guidelines from vaginal to oral, Planned Parenthood apparently continues to violate the FDA usage suggestions by telling women to take the second part of the abortion pill process at home.

The FDA says that should be done in a medical office to monitor the women for any complications.